Recurrence of cervical intraepithelial neoplasia grades 2 or 3 in HIV-infected women treated by large loop excision of the transformation zone (LLETZ)
Keywords:
Cervical intraepithelial neoplaosia, Prognosis, HIV seropositivity, Recurrence, ElectrosurgeryAbstract
CONTEXT AND OBJECTIVE: Women infected by HIV are more likely to have cervical cancer and its precursors. Treatment of the precursor lesions can prevent this neoplasia. The aim of this study was to assess the likelihood of recurrent cervical intraepithelial neoplasia grades 2 or 3 (CIN 2-3) in HIV-infected women, compared with HIV-negative women, all treated by large loop excision of the transformation zone (LLETZ). DESIGN AND SETTING: A cohort study in Instituto Fernandes Figueira, Fundação Oswaldo Cruz (IFF-Fiocruz), Rio de Janeiro. METHOD: 55 HIV-positive and 212 HIV-negative women were followed up after LLETZ for CIN 2-3 (range: 6-133 months). RESULTS: The incidence of recurrent CIN 2-3 was 30.06/10,000 woman-months in the HIV-positive group and 4.88/10,000 woman-months in the HIV-negative group (relative risk, RR = 6.16; 95% confidence interval, CI: 2.07-18.34). The likelihood of recurrence reached 26% at the 62nd month of follow-up among the HIV-positive women, and remained stable at almost 0.6% at the 93rd month of follow-up among the HIV-negative women. We were unable to demonstrate other prognostic factors relating to CIN recurrence, but the use of highly active antiretroviral therapy (HAART) may decrease the risk of this occurrence among HIV patients. CONCLUSION: After LLETZ there is a higher risk of recurrence of CIN 2-3 among HIV-positive women than among HIV-negative women. This higher risk was not influenced by margin status or grade of cervical disease treated. The use of HAART may decrease the risk of this occurrence in HIV patients.
Downloads
References
UNAIDS. AIDS epidemic update: special report on HIV/AIDS. Geneva: Joint United Nations Programme on HIV/AIDS (UN- AIDS) and World Health Organization (WHO); 2006. p. 1-96.
Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced hu- man immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853-60.
Brito AM, Castilho EA, Szwarcwald CL. Regionalpatternsofthetempo- ral evolution of the AIDS epidemic in Brazil following the introduction of antiretroviral therapy. Braz J Infec Dist. 2005;9(1):9-19.
Massad LS, Ahdieh L, Benning L, et al. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women’s interagency HIV study. J Acquir Immune Defic Syndr. 2001;27(5):432-42.
Grinsztejn B. Prevalência de infecções sexualmente transmissíveis e estudo dos fatores de risco para infecção pelo HPV numa coorte de mulheres infectadas pelo HIV no Rio de Janeiro. [thesis]. Rio de Janeiro: Faculdade de Medicina da Universidade Federal do Rio de Janeiro; 2001.
Russomano F, Bastos FI, Camargo MJ, et al. High prevalence of genital intra-epithelial neoplasia in a cohort of HIV infected women in Rio de Janeiro (RJ), Brazil. In: XIV International AIDS Conference. July 7-12, 2002 (abstract no ThPeC7549). Available from: http://gateway.nlm.nih.gov/MeetingAb- stracts/102256183.html. Accessed in 2007 (Nov 9).
Suárez Rincón AE, Vázquez Valls E, Ramírez Rodríguez M, Mon- toya Fuentes H, Covarrubias Rodríguez M de L, Sánchez Corona.
J. Lesiones escamosas intraepiteliaes en pacientes VIH seropositivas. Su frecuencia y asociación con factores de riesgo para neoplasia cervical. [Squamous intra-epithelial lesions in HIV seropositive females. Their frequency and association with cervical neoplasia risk factors]. Ginecol Obstet Mex. 2003;71:32-43.
Hluangdansakul W, Phinchantra P, Bowonwatanuwong C. Prevalence of SIL and SCCA in human immunodeficiency virus-seropositive women at anonymous clinic in Chonburi Hospital. J Med Assoc Thai. 2006;89(3):289-93.
Petry KU, Scheffel D, Bode U, et al. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer. 1994;57(6):836-40.
Olaitan A, Mocroft A, McCarthy K, Phillips A, Reid W, John- son M. Cervical abnormality and sexually transmitted disease screening in human immunodeficiency virus-positive women. Obstet Gynecol. 1997;89(1):71-5.
Wright TC Jr, Koulos J, Schnoll F, et al. Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus: outcome after loop electrosurgical excision. Gynecol Oncol. 1994;55(2):253-8.
Fruchter RG, Maiman M, Sedlis A, Bartley L, Camilien L, Arrastia CD. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol. 1996;87(3):338-44.
Robinson WR, Hamilton CA, Michaels SH, Kissinger P. Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immuno- deficiency virus. Am J Obstet Gynecol. 2001;184(4):538-43.
Chirenje ZM, Rusakaniko S, Akino V, Munjoma M, Mlingo
M. Effect of HIV Disease in Treatment Outcome of Cervical Squamous Intraepithelial Lesions Among Zimbabwean Women. J Low Genit Tract Dis. 2003;7(1):16-21.
Tebeu PM, Major AL, Mhawech P, Rapiti E. The recur- rence of cervical intraepithelial neoplasia in HIV-positive women: a review of the literature. Int J STD AIDS. 2006;17(8):507-11.
Massad LS, Fazzari MJ, Anastos K, et al. Outcomes after treat- ment of cervical intraepithelial neoplasia among women with HIV. J Low Genit Tract Dis. 2007;11(2):90-7.
Schwartz LB, Carcangiu ML, Bradham L, Schwartz PE. Rapidly progressive squamous cell carcinoma of the cervix coexisting with human immunodeficiency virus infection: clinical opinion. Gynecol Oncol. 1991;41(3):255-8.
Del Priore G, Lee MJ, Barnes M, Garcia P, Till M. The inad- equacy of standard treatment of dysplasias in a woman with acquired immune deficiency syndrome. Int J Gynaecol Obstet. 1994;47(3):273-4.
Stratton P, Ciacco KH. Cervical neoplasia in the patient with HIV infection. Curr Opin Obstet Gynecol. 1994;6(1): 86-91.
Holcomb K, Matthews RP, Chapman JE, et al. The efficacy of cervical conization in the treatment of cervical intraepi- thelial neoplasia in HIV-positive women. Gynecol Oncol. 1999;74(3):428-31.
Kuhn L, Sun XW, Wright TC Jr. Human immunodeficiency virus infection and female lower genital tract malignancy. Curr Opin Obstet Gynecol. 1999;11(1):35-9.
Robinson W 3rd. Invasive and preinvasive cervical neoplasia in human immunodeficiency virus-infected women. Semin Oncol. 2000;27(4):463-70.
Tate DR, Anderson RJ. Recrudescence of cervical dysplasia among women who are infected with the human immunodeficiency virus: a case-control analysis. Am J Obstet Gynecol. 2002;186(5):880-2.
Gilles C, Manigart Y, Konopnicki D, Barlow P, Rozenberg S. Management and outcome of cervical intraepithelial neoplasia lesions: a study of matched cases according to HIV status. Gynecol Oncol. 2005;96(1):112-8.
Heard I, Potard V, Foulot H, Chapron C, Costagliola D, Kazatchkine MD. High rate of recurrence of cervical intraepi- thelial neoplasia after surgery in HIV-positive women. J Acquir Immune Defic Syndr. 2005;39(4):412-8.
Heard I, Tassie JM, Kazatchkine MD, Orth G. Highly ac- tive antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women. AIDS. 2002;16(13):1799-802.
Maiman M, Fruchter RG, Serur E, Levine PA, Arrastia CD, Sedlis A. Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obstet Gynecol. 1993;82(2):170-4.
Frega A, Biamonti A, Maranghi L, et al. Follow-up of high-grade squamous intra-epithelial lesions (H-SIls) in human immu- nodeficiency virus (HIV)-positive and human papillomavirus (HPV)-positive women. analysis of risk factors. Anticancer Res. 2006;26(4B):3167-70.
Prendiville W. Large loop excision of the transformation zone. In: Prendiville W, editor. Large loop excision of the transformation zone. A practical guide to LLETZ. London: Chapman & Hall Medical; 1993. p. 36-58.
Kleinbaum DG, Kupper LL, Morgerstern H. Confounding. In: Kleinbaum DG, Kupper LL, Morgerstern H, editors. Epidemiologic research: Principles and quantitative methods. New York: John Wiley & Sons; 1982. p. 242-65.
